Revelation Biosciences, Inc. (REVB, REVBW)

CIK 1810560 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Revelation Biosciences, Inc..

Recent SEC filings

FiledFormAccession number
Aug 19, 20268-K0001193125-26-357120
Aug 18, 202640001193125-26-355663
Aug 18, 202640001193125-26-355659
Aug 18, 202640001193125-26-355662
Aug 18, 202640001193125-26-355658
Aug 18, 202640001193125-26-355661
Aug 14, 2026SCHEDULE 13G/A0001172661-26-003611
Aug 6, 20268-K0001193125-26-338097
Aug 6, 202610-Q0001193125-26-337967
Jul 13, 20268-A12B0001193125-26-302077
Jul 13, 20268-K0001193125-26-302008
Jun 24, 20268-K0001193125-26-281200
Jun 1, 20268-K0001193125-26-251784
May 15, 2026SCHEDULE 13G0001172661-26-002179
May 11, 2026DEF 14A0001193125-26-215804
May 11, 2026ARS0001193125-26-215826
May 7, 202610-Q0001193125-26-211871
May 7, 20268-K0001193125-26-212064
May 1, 202640001193125-26-201764
May 1, 202640001193125-26-201769
Apr 30, 2026PRE 14A0001193125-26-196729
Apr 15, 2026S-80001193125-26-157022
Mar 19, 20268-K0001193125-26-116012
Feb 26, 20268-K0001193125-26-076833
Feb 26, 202610-K0001193125-26-076552